Drug toxicity
|
0.300 |
Biomarker
|
group |
CTD_human |
Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
|
26077125 |
2016 |
Adverse reaction to drug
|
0.300 |
Biomarker
|
group |
CTD_human |
Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
|
26077125 |
2016 |
Drug toxicity
|
0.300 |
Biomarker
|
group |
CTD_human |
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia.
|
25007187 |
2014 |
Adverse reaction to drug
|
0.300 |
Biomarker
|
group |
CTD_human |
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia.
|
25007187 |
2014 |
Drug toxicity
|
0.300 |
Biomarker
|
group |
CTD_human |
Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
|
21064136 |
2011 |
Adverse reaction to drug
|
0.300 |
Biomarker
|
group |
CTD_human |
Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
|
21064136 |
2011 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
|
21501481 |
2011 |
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
|
21501481 |
2011 |
Brain Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity.
|
20714149 |
2010 |
Hyperammonemia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity.
|
20714149 |
2010 |
Drug toxicity
|
0.300 |
Biomarker
|
group |
CTD_human |
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
|
19648163 |
2009 |
Adverse reaction to drug
|
0.300 |
Biomarker
|
group |
CTD_human |
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.
|
19648163 |
2009 |
Digestive System Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.
|
18281538 |
2008 |
Head and Neck Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |
Head Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |
Neck Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |
Neoplasm Recurrence, Local
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer.
|
18192902 |
2008 |
Cancer of Neck
|
0.300 |
Biomarker
|
disease |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |
Cancer of Digestive System
|
0.300 |
Biomarker
|
disease |
CTD_human |
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.
|
18281538 |
2008 |
Cancer of Head
|
0.300 |
Biomarker
|
disease |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |
Upper Aerodigestive Tract Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |
Hereditary Diffuse Gastric Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer.
|
18652704 |
2008 |
Hereditary Diffuse Gastric Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker.
|
18505590 |
2008 |
Hereditary Diffuse Gastric Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
|
19020767 |
2008 |